Medical Pharmacology: Immunopharmacology Practice Questions
Calcineurin Inhibitors II (Cyclosporin,
Tacrolimus)
Cyclosporine
Tacrolimus
Click on the correct answer.
Cyclosporine:
Binds to cyclophilin A which is the prominent immunophilin localized in T cells.
Binding of cyclosporine to cyclophilin A Increases cyclophilin-mediated inhibition of calcineurin.
Both
Neither
T-cell activation increases calcineurin activity leading to activation of nuclear factor of activated T cells (NFAT). This enhancement of NFAT promotes interleukin-2 (IL-2) in addition to other cytokines associated with the immune response.
True
False
Calcineurin promotes activation of NFκB which is very important for T-cell function and survival.
True
False
Cyclosporine:
After oral administration, ciclosporine is absorbed incompletely (20%-50%) and slowly.
Absorbed drug is mainly metabolized by the cytochrome P450 drug metabolizing system and is associated with drug-drug interactions.
Both
Neither
Drug-drug interactions associated with cyclosporine administration is an important factor in interpatient bioavailability differences.
The primary use of cyclosporine is in preventing rejection associated with allogenic kidney, liver, and heart transplantation. Prednisone in this context is often given at the same time.
True
False
Which one(s) of the following agents inhibit transcription of IL-2 thus decreasing clonal T-helper cell clonal proliferation?
Tacrolimus (Envarsus)
Sirolimus (Rapamune)
Both
Either
Clinical use/uses for cyclosporine (FDA approved uses):
For treating severe plaque psoriasis
Treating active rheumatoid arthritis (not typically used for this indication)
Both
Neither
Cyclosporine is considered a first-line treatment for pure
red cell aplasia.
If you wish to return to the Table of Contents
in ENGLISH, press the RETURN button above.
Otherwise, if the text is NOT displayed in
English and you are ready to leave this page,
Press here
to return to the Table of Contents
Source Material:
Rothlin C Gutkind J Chapter 39
Immunosuppressants, Immunomodulation and Tolerance In
Goodman & Gilman's The Pharmacological Basis of Therapeutics
(Brunton LL Knollman BC eds) McGraw Hill LLC (2023).
Lake D & Briggs A Ch 55 Immunopharmacology
in Katzung's Basic & Clinical Pharmacology (Vanderah TW, ed)
16e McGraw Hill 2023.
Chrouos G Ch 39 Adrenocorticosteroids &
Adrenocortical Antagonists in Katzung's Basic & Clinical
Pharmacology (Vanderah TW, ed) 16e McGraw Hill 2023
Brezinski E Klickstein L Armstrong A Ch 46
Pharmacology of Immunosuppression in Principles of
Pharmacology: The Pathophysiologic Basis of Drug Therapy.
(Golan DE Armstrong EJ Armstrong AW, eds) 4e 2017 ls) 4e
2017
Ritter JM Flower R Henderson G Loke YK
MacEwan D Robinson E Fullerton J Ch 54 Anti-inflammatory and
Immunosuppressant Drugs Rang & Dale's Pharmacology 10e
Elsevier 2024.
Burchum J Rosenthal L Lehne's Pharmacology
for Nursing Care Ch 72 Immunosuppressants Elsevier 2022.
Burchum J Rosenthal L Lehne's Pharmacology
for Nursing Care Ch 75 Glucocorticoids in Nonendrocrine
Disorders Elsevier 2022.
Bass A Rogatsky Ch 32 Immunomodulatory Drugs
in Goldman-Cecil Medicine (Goldman L Schafer, eds) Elsevier
26e 2020
Leiva M Takemoto Ch 238 Immunosuppressants in
Lippincott Illustrated Reviews: Pharmacology 8e ((Walen et
al, eds) Wolters Kluwer 2023.
Hall J Hall M Ch 78 Adrenocortical
Hormones Guyton and Hall Textbook of Medical Physiology 14e
Elsevier 2021.